Tomas Ø. Jensen

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Thomas L Holland, Adit A. Ginde, Roger Paredes et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +4

Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study

Thomas Benfield, Jacob Bodilsen, Christian Brieghel et al. · Clinical Infectious Diseases · 2021 · 93 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +12

Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge

Natascha Josephine Ulstrand Fuglebjerg, Tomas Ø. Jensen, Nils Hoyer et al. · International Journal of Infectious Diseases · 2020 · 78 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +8

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study

Ole S. Søgaard, Joanne Reekie, Işık Somuncu Johansen et al. · Clinical Microbiology and Infection · 2022 · 66 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study

Jon Gitz Holler, Robert Eriksson, Tomas Ø. Jensen et al. · BMC Infectious Diseases · 2021 · 49 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +16